Home / Brands / Merck Sharp & Dohme
Merck Sharp & Dohme Recalls
5 recalls on record · January 13, 2021 to December 31, 2025 · Drugs
Recalls by year
21
22
25
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
December 31, 2025DrugsFDA
Merck Sharp & Dohme LLC recalls Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufacture
Hazard: Presence of particulate matter: potential presence of metal particulates in the product.
December 31, 2025DrugsFDA
Merck Sharp & Dohme LLC recalls Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme L
Hazard: Presence of particulate matter: potential presence of metal particulates in the product.
April 13, 2022DrugsFDA
MERCK SHARP & DOHME CORP recalls Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sampl
Hazard: Presence of foreign substance: Presence of stainless steel particulates in tablets.
November 10, 2021DrugsFDA
MERCK SHARP & DOHME CORP recalls Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a
Hazard: Presence of Particulate Matter: Identified as Glass Particles
January 13, 2021DrugsFDA
Merck Sharp & Dohme recalls Zerbaxa (ceftolozane and tazobactam) 1.5g per vial for injection, Single-Dose vial, Rx only, Manuf. for: Merck Sharp & D
Hazard: Lack of assurance of sterility: The results of sterility tests of seven batches of product were out of specification. Five of these batches tested positive for Ralstonia pickettii and two batches produced turbid results that could not be further identified. While all product distributed to the market has met the registered specifications for release, including for sterility, it was manufactured on the same equipment as the affected batches.